High expression of SIRT1 was significantly associated with lymphatic invasion (P = 0.028), vessel invasion (P = 0.016), and lymph node metastasis (P = 0.014) and tended to be associated with more advanced disease stages (Table 1). Here, SIRT1 is linked to metastatic malignant neoplasm in the lymph nodes.